Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

CVRx, Inc. Common Stock

CVRX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CVRX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CVRX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CVRX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CVRX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CVRX holdings by institutional investors

Quarterly net insider trading by CVRX's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for CVRX

Quiver Logo

No former government officials on record as having lobbied for CVRX

Revolving Door Dashboard

CVRX Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

CVRX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CVRX Income Statement
CVRX Balance Sheet
CVRX Cash Flow
U.S. Patents

New CVRX patent grants

  • Patent Title: Connection structure for tablet Mar. 24, 2026
  • Patent Title: Antenna for use with medical device May. 21, 2024
  • Patent Title: Display screen or a portion thereof with graphical user interface Oct. 03, 2023
  • Patent Title: Display screen or a portion thereof with graphical user interface Oct. 03, 2023
  • Patent Title: Display screen or a portion thereof with graphical user interface Sep. 26, 2023
  • Patent Title: Display screen or a portion thereof with graphical user interface Sep. 26, 2023
  • Patent Title: Implant tool and improved electrode design for minimally invasive procedure Dec. 06, 2016
  • Patent Title: Hypertension treatment device and method for mitigating rapid changes in blood pressure Oct. 04, 2016
  • Patent Title: Electrode structures and methods for their use in cardiovascular reflex control Aug. 30, 2016
  • Patent Title: Method for monitoring physiological cycles of a patient to optimize patient therapy Aug. 16, 2016
  • Patent Title: Adapter for connection to pulse generator May. 24, 2016
  • Patent Title: Devices and methods for improved placement of implantable medical devices Dec. 01, 2015
  • Patent Title: Electrode structures and methods for their use in cardiovascular reflex control Jun. 02, 2015
  • Patent Title: Hypertension treatment device and method for mitigating rapid changes in blood pressure May. 05, 2015
  • Patent Title: System for setting programmable parameters for an implantable hypertension treatment device Mar. 10, 2015
  • Patent Title: Devices and methods for treatment of heart failure and associated conditions Feb. 03, 2015
  • Patent Title: Electrode structures and methods for their use in cardiovascular reflex control Nov. 04, 2014
  • Patent Title: Devices and methods for cardiovascular reflex treatments Sep. 16, 2014
  • Patent Title: Implant tool and improved electrode design for minimally invasive procedure Jul. 22, 2014
  • Patent Title: Devices and methods for electrode implantation Jun. 17, 2014
  • Patent Title: Devices and methods for treatment of heart failure and associated conditions Jun. 03, 2014
  • Patent Title: Electrode structures and methods for their use in cardiovascular reflex control May. 06, 2014
  • Patent Title: Baroreflex modulation using light-based stimulation May. 06, 2014
  • Patent Title: Automatic baroreflex modulation responsive to adverse event Apr. 29, 2014
  • Patent Title: System for setting programmable parameters for an implantable hypertension treatment device Apr. 29, 2014
  • Patent Title: Devices and methods for treatment of heart failure and associated conditions Apr. 15, 2014
  • Patent Title: Electrode array structures and methods of use for cardiovascular reflex control Dec. 31, 2013
  • Patent Title: System and method for sustained baroreflex stimulation Dec. 10, 2013
  • Patent Title: Devices and methods for treatment of heart failure and associated conditions Dec. 03, 2013
  • Patent Title: Baroreflex activation therapy with incrementally changing intensity Nov. 26, 2013
  • Patent Title: Devices and methods for cardiovascular reflex control Nov. 12, 2013
  • Patent Title: Measurement of patient physiological parameters Oct. 29, 2013
  • Patent Title: Devices and methods for electrode implantation Oct. 15, 2013
  • Patent Title: Measurement of patient physiological parameters Aug. 27, 2013
  • Patent Title: Baroreflex activation for pain control, sedation and sleep Jul. 02, 2013
  • Patent Title: Implant tool and improved electrode design for minimally invasive procedure May. 07, 2013
  • Patent Title: Devices and methods for treatment of heart failure and associated conditions Mar. 19, 2013
  • Patent Title: Devices and methods for treatment of heart failure and associated conditions Dec. 04, 2012
  • Patent Title: Devices and methods for treatment of heart failure and associated conditions Nov. 27, 2012
  • Patent Title: Method and apparatus for stimulation of baroreceptors in pulmonary artery Oct. 16, 2012
  • Patent Title: Devices and methods for treatment of heart failure and associated conditions Sep. 11, 2012
  • Patent Title: Devices, systems, and methods for improving left ventricular structure and function using baroreflex activation therapy Aug. 21, 2012
  • Patent Title: Baroreflex activation for sedation and sleep Jul. 17, 2012
  • Patent Title: Method for monitoring physiological cycles of a patient to optimize patient therapy Jul. 03, 2012
  • Patent Title: Methods and devices for controlling battery life in an implantable pulse generator Apr. 03, 2012
  • Patent Title: Measurement of patient physiological parameters Feb. 14, 2012
  • Patent Title: Devices and methods for cardiovascular reflex control Dec. 27, 2011
  • Patent Title: Baroreflex modulation to gradually decrease blood pressure Nov. 15, 2011
  • Patent Title: Connection structures for extra-vascular electrode lead body Sep. 06, 2011
  • Patent Title: Devices and methods for cardiovascular reflex control via coupled electrodes May. 24, 2011
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to CVRX from public contracts

CVRX News

Recent insights relating to CVRX

CNBC Recommendations

Recent picks made for CVRX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CVRX

CVRX Analyst Ratings

CVRX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CVRX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CVRX stock a Buy, Sell, or Hold?

  • What is the price target for $CVRX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CVRX Top Shareholders
Shareholder
Shares Held
CVRX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CVRX stock?

  • Who owns the most shares of $CVRX stock?

  • What funds own $CVRX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CVRX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CVRX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CVRX

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

  • Address Minneapolis, MN
  • Market Cap 77.0 million
  • Employees 223
  • Industrial Classification Surgical & Medical Instruments & Apparatus

CVRx, Inc. Common Stock (CVRX) Historical Stock Prices

CVRx, Inc. Common Stock (CVRX) closed at $2.89 on September 22, 2026. Over the past year its adjusted close ranged from $2.37 to $10.81. Daily prices go back to June 30, 2021, 1,313 trading days in all.

  • 1 month+1.76%
  • 3 months-43.88%
  • Year to date-59.30%
  • 1 year-61.62%
  • 3 years-80.15%
  • 5 years-81.39%
  • Max-89.68%
See every congressional and insider trade on the CVRX price chart

Quiver Premium charts CVRX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 2.95 3.07 2.86 2.89 2.89 666,182
Sep 21, 2026 3.03 3.06 2.91 2.97 2.97 289,629
Sep 18, 2026 2.99 3.06 2.92 3.04 3.04 810,573
Sep 17, 2026 3.04 3.10 2.98 3.00 3.00 301,154
Sep 16, 2026 2.99 3.13 2.92 3.02 3.02 415,886
Sep 15, 2026 2.99 3.08 2.85 3.00 3.00 494,942
Sep 14, 2026 2.86 3.00 2.79 3.00 3.00 548,386
Sep 11, 2026 2.86 2.90 2.75 2.88 2.88 1,002,649
Sep 10, 2026 2.83 2.86 2.70 2.86 2.86 373,409
Sep 9, 2026 2.90 2.95 2.76 2.83 2.83 555,242
Sep 8, 2026 3.03 3.05 2.81 2.93 2.93 619,561
Sep 4, 2026 2.99 3.11 2.96 3.05 3.05 856,028
Sep 3, 2026 3.11 3.17 2.98 3.01 3.01 614,544
Sep 2, 2026 3.06 3.16 2.96 3.07 3.07 530,032
Sep 1, 2026 2.93 3.06 2.90 3.04 3.04 780,721
Aug 31, 2026 2.97 2.99 2.81 2.96 2.96 737,784
Aug 28, 2026 3.03 3.15 2.94 2.95 2.95 497,116
Aug 27, 2026 3.25 3.29 3.02 3.04 3.04 449,034
Aug 26, 2026 3.31 3.40 3.15 3.27 3.27 884,492
Aug 25, 2026 3.17 3.42 3.13 3.37 3.37 1,123,956
Aug 24, 2026 2.99 3.29 2.86 3.15 3.15 1,620,454
Aug 21, 2026 2.86 2.96 2.82 2.84 2.84 742,074
Aug 20, 2026 2.81 2.95 2.77 2.84 2.84 746,497
Aug 19, 2026 2.75 2.85 2.73 2.82 2.82 586,676
Aug 18, 2026 2.77 2.99 2.71 2.75 2.75 639,087
Aug 17, 2026 3.04 3.08 2.74 2.75 2.75 1,036,926
Aug 14, 2026 3.08 3.24 2.90 3.08 3.08 1,897,812
Aug 13, 2026 2.65 2.97 2.65 2.94 2.94 1,223,391
Aug 12, 2026 2.55 2.74 2.50 2.73 2.73 1,372,273
Aug 11, 2026 2.31 2.68 2.31 2.60 2.60 2,587,212
Aug 10, 2026 2.39 2.39 2.20 2.37 2.37 2,779,819
Aug 7, 2026 3.01 3.08 2.30 2.39 2.39 14,773,453
Aug 6, 2026 5.59 6.00 5.59 5.94 5.94 591,250
Aug 5, 2026 5.49 5.64 5.29 5.58 5.58 174,994
Aug 4, 2026 5.50 5.58 5.46 5.49 5.49 134,536
Aug 3, 2026 5.24 5.59 5.24 5.50 5.50 128,811
Jul 31, 2026 5.36 5.36 5.03 5.17 5.17 95,412
Jul 30, 2026 5.20 5.39 4.93 5.38 5.38 268,691
Jul 29, 2026 4.98 5.13 4.86 4.95 4.95 153,855
Jul 28, 2026 4.96 5.15 4.88 4.95 4.95 153,586
Jul 27, 2026 4.81 5.00 4.75 4.88 4.88 248,254
Jul 24, 2026 4.95 4.99 4.70 4.74 4.74 197,353
Jul 23, 2026 5.04 5.09 4.87 4.89 4.89 187,457
Jul 22, 2026 4.94 5.10 4.86 5.09 5.09 102,768
Jul 21, 2026 4.75 5.03 4.68 4.97 4.97 311,159
Jul 20, 2026 4.93 4.97 4.64 4.77 4.77 347,482
Jul 17, 2026 5.35 5.42 4.91 4.91 4.91 276,119
Jul 16, 2026 5.27 5.90 5.27 5.39 5.39 685,895
Jul 15, 2026 5.21 5.32 5.10 5.27 5.27 107,412
Jul 14, 2026 5.40 5.42 5.08 5.16 5.16 221,290
Jul 13, 2026 5.42 5.61 5.40 5.43 5.43 225,354
Jul 10, 2026 5.17 5.44 5.16 5.43 5.43 140,461
Jul 9, 2026 5.23 5.36 5.03 5.20 5.20 203,370
Jul 8, 2026 5.64 5.68 5.19 5.27 5.27 223,998
Jul 7, 2026 5.66 5.93 5.53 5.74 5.74 307,627
Jul 6, 2026 5.60 5.72 5.46 5.63 5.63 277,611
Jul 2, 2026 5.58 5.75 5.46 5.60 5.60 149,552
Jul 1, 2026 5.12 5.53 5.03 5.50 5.50 332,198
Jun 30, 2026 5.94 5.94 5.05 5.14 5.14 414,999
Jun 29, 2026 5.78 6.01 5.55 5.94 5.94 343,571
Jun 26, 2026 5.25 5.90 5.25 5.86 5.86 791,353
Jun 25, 2026 5.16 5.48 5.15 5.25 5.25 193,850
Jun 24, 2026 5.11 5.29 5.08 5.16 5.16 344,962
Jun 23, 2026 4.81 5.30 4.81 5.15 5.15 310,797
Jun 22, 2026 4.93 5.15 4.76 4.86 4.86 434,819
Jun 18, 2026 4.92 5.00 4.85 4.95 4.95 293,201
Jun 17, 2026 4.85 5.05 4.83 4.83 4.83 241,442
Jun 16, 2026 5.00 5.00 4.77 4.87 4.87 101,035
Jun 15, 2026 5.15 5.24 4.92 4.98 4.98 90,249
Jun 12, 2026 4.91 5.04 4.81 5.03 5.03 264,396
Jun 11, 2026 4.83 5.18 4.77 4.89 4.89 474,970
Jun 10, 2026 5.19 5.22 4.82 4.83 4.83 445,528
Jun 9, 2026 5.25 5.41 4.83 5.20 5.20 401,654
Jun 8, 2026 5.43 5.56 5.33 5.40 5.40 242,040
Jun 5, 2026 5.87 5.95 5.33 5.38 5.38 234,821
Jun 4, 2026 5.43 5.89 5.34 5.88 5.88 310,432
Jun 3, 2026 5.47 5.58 5.33 5.39 5.39 284,136
Jun 2, 2026 5.39 5.51 5.31 5.43 5.43 238,271
Jun 1, 2026 5.45 5.75 5.37 5.43 5.43 262,635
May 29, 2026 5.62 5.77 5.52 5.58 5.58 162,538
May 28, 2026 5.77 5.91 5.49 5.63 5.63 332,331
May 27, 2026 6.00 6.23 5.77 5.78 5.78 189,816
May 26, 2026 6.05 6.23 5.87 6.08 6.08 124,149
May 22, 2026 6.13 6.43 6.09 6.11 6.11 245,922
May 21, 2026 6.04 6.25 5.95 6.07 6.07 222,987
May 20, 2026 6.02 6.29 5.80 6.06 6.06 252,776
May 19, 2026 5.85 6.09 5.70 6.01 6.01 296,113
May 18, 2026 6.01 6.26 5.74 5.94 5.94 543,372
May 15, 2026 5.70 6.21 5.65 5.99 5.99 1,074,942
May 14, 2026 5.25 6.19 5.21 5.74 5.74 1,037,651
May 13, 2026 5.27 5.66 5.00 5.22 5.22 664,401
May 12, 2026 6.67 6.71 5.21 5.27 5.27 864,413
May 11, 2026 6.92 7.23 6.75 6.92 6.92 361,359
May 8, 2026 7.22 7.23 6.69 6.83 6.83 199,636
May 7, 2026 7.14 7.36 7.06 7.32 7.32 162,632
May 6, 2026 7.54 7.68 7.00 7.07 7.07 278,713
May 5, 2026 7.91 7.92 7.40 7.50 7.50 160,487
May 4, 2026 7.96 8.14 7.72 7.79 7.79 153,329
May 1, 2026 7.55 8.06 7.42 7.97 7.97 346,562
Apr 30, 2026 6.85 7.58 6.52 7.51 7.51 257,437
Apr 29, 2026 7.45 7.45 6.84 6.87 6.87 249,362
Apr 28, 2026 7.60 7.79 7.45 7.48 7.48 145,631
Apr 27, 2026 7.71 7.98 7.63 7.65 7.65 97,221
Apr 24, 2026 7.67 7.84 7.43 7.72 7.72 147,094
Apr 23, 2026 8.19 8.19 7.51 7.64 7.64 234,375
Apr 22, 2026 7.65 8.05 7.32 7.98 7.98 288,453
Apr 21, 2026 7.29 7.84 7.00 7.60 7.60 556,532
Apr 20, 2026 7.32 7.45 7.19 7.24 7.24 317,128
Apr 17, 2026 7.42 7.73 7.24 7.36 7.36 442,981
Apr 16, 2026 7.45 7.73 7.31 7.36 7.36 253,952
Apr 15, 2026 7.71 7.78 7.26 7.48 7.48 211,013
Apr 14, 2026 7.93 8.48 7.69 7.72 7.72 372,126
Apr 13, 2026 7.25 7.91 7.06 7.81 7.81 326,783
Apr 10, 2026 7.49 7.49 6.64 7.16 7.16 491,849
Apr 9, 2026 7.76 7.88 7.03 7.48 7.48 319,670
Apr 8, 2026 8.45 8.78 7.64 7.83 7.83 290,971
Apr 7, 2026 8.94 9.02 8.30 8.37 8.37 165,181
Apr 6, 2026 9.01 9.23 8.78 9.05 9.05 91,590
Apr 2, 2026 8.92 9.11 8.66 9.01 9.01 135,402
Apr 1, 2026 9.50 9.76 8.85 9.10 9.10 290,415
Mar 31, 2026 8.84 9.71 8.84 9.46 9.46 154,017
Mar 30, 2026 8.83 8.97 8.47 8.86 8.86 363,978
Mar 27, 2026 9.21 9.38 8.81 8.91 8.91 176,991
Mar 26, 2026 9.25 9.84 9.07 9.28 9.28 146,864
Mar 25, 2026 8.59 9.48 8.48 9.38 9.38 250,668
Mar 24, 2026 8.33 8.58 8.13 8.51 8.51 177,706
Mar 23, 2026 8.69 8.99 8.35 8.42 8.42 412,464
Mar 20, 2026 8.57 8.86 8.27 8.69 8.69 235,596
Mar 19, 2026 8.35 9.04 8.35 8.63 8.63 230,203
Mar 18, 2026 8.26 8.62 8.04 8.50 8.50 204,675
Mar 17, 2026 7.83 8.40 7.53 8.33 8.33 183,619
Mar 16, 2026 7.69 7.95 7.47 7.87 7.87 109,656
Mar 13, 2026 7.39 7.95 7.10 7.53 7.53 238,883
Mar 12, 2026 7.74 7.79 7.41 7.44 7.44 142,797
Mar 11, 2026 7.42 7.90 7.33 7.83 7.83 141,065
Mar 10, 2026 7.79 7.80 7.41 7.47 7.47 252,536
Mar 9, 2026 8.13 8.22 7.68 7.86 7.86 242,809
Mar 6, 2026 8.19 8.41 8.05 8.25 8.25 195,589
Mar 5, 2026 8.34 8.49 8.05 8.37 8.37 193,576
Mar 4, 2026 8.18 8.69 8.00 8.49 8.49 189,289
Mar 3, 2026 8.01 8.35 7.75 8.18 8.18 219,224
Mar 2, 2026 7.90 8.50 7.75 8.22 8.22 584,856
Feb 27, 2026 8.02 8.30 7.95 8.16 8.16 462,598
Feb 26, 2026 7.64 8.15 7.34 8.06 8.06 729,835
Feb 25, 2026 7.31 7.69 7.13 7.65 7.65 589,845
Feb 24, 2026 6.76 7.61 6.76 7.24 7.24 705,659
Feb 23, 2026 6.44 7.22 6.42 6.79 6.79 1,071,905
Feb 20, 2026 5.26 6.49 5.22 6.11 6.11 951,192
Feb 19, 2026 5.03 5.35 4.82 5.28 5.28 617,031
Feb 18, 2026 4.78 4.94 4.43 4.85 4.85 426,562
Feb 17, 2026 4.93 4.99 4.37 4.74 4.74 476,453
Feb 13, 2026 5.60 5.67 4.71 4.95 4.95 701,789
Feb 12, 2026 6.11 6.22 5.67 5.69 5.69 202,542
Feb 11, 2026 6.67 6.67 6.01 6.08 6.08 218,536
Feb 10, 2026 6.60 7.03 6.52 6.69 6.69 209,048
Feb 9, 2026 6.51 6.57 6.27 6.55 6.55 141,478
Feb 6, 2026 6.69 6.82 6.44 6.55 6.55 224,912
Feb 5, 2026 6.65 6.94 6.51 6.64 6.64 222,598
Feb 4, 2026 6.97 6.97 6.36 6.72 6.72 296,026
Feb 3, 2026 7.10 7.26 6.71 6.96 6.96 175,587
Feb 2, 2026 6.81 7.42 6.59 7.12 7.12 582,927
Jan 30, 2026 7.11 7.14 6.71 6.85 6.85 263,951
Jan 29, 2026 7.15 7.30 6.86 7.01 7.01 332,438
Jan 28, 2026 7.59 7.80 7.10 7.16 7.16 233,992
Jan 27, 2026 7.33 7.60 6.96 7.54 7.54 375,839
Jan 26, 2026 7.31 7.84 7.19 7.33 7.33 676,908
Jan 23, 2026 6.55 7.84 6.46 7.31 7.31 976,161
Jan 22, 2026 6.01 6.77 5.86 6.56 6.56 645,994
Jan 21, 2026 5.61 6.24 5.58 6.04 6.04 478,757
Jan 20, 2026 5.16 5.65 5.11 5.59 5.59 493,692
Jan 16, 2026 5.50 5.99 5.16 5.21 5.21 409,029
Jan 15, 2026 6.09 6.09 5.44 5.47 5.47 378,196
Jan 14, 2026 6.08 6.08 5.33 6.05 6.05 480,835
Jan 13, 2026 7.26 7.60 6.03 6.11 6.11 469,862
Jan 12, 2026 8.06 8.15 6.96 7.31 7.31 323,071
Jan 9, 2026 8.50 8.65 8.04 8.11 8.11 159,424
Jan 8, 2026 8.30 8.65 8.29 8.45 8.45 197,489
Jan 7, 2026 7.94 8.37 7.83 8.22 8.22 195,052
Jan 6, 2026 7.59 7.96 7.50 7.92 7.92 213,912
Jan 5, 2026 7.10 7.80 7.04 7.67 7.67 275,915
Jan 2, 2026 7.15 7.33 6.99 7.10 7.10 163,134
Dec 31, 2025 7.15 7.29 6.98 7.10 7.10 168,756
Dec 30, 2025 7.23 7.37 7.18 7.18 7.18 98,309
Dec 29, 2025 7.39 7.56 7.00 7.22 7.22 339,857
Dec 26, 2025 7.62 7.74 7.38 7.42 7.42 177,974
Dec 24, 2025 7.63 7.92 7.49 7.68 7.68 156,729
Dec 23, 2025 7.74 7.79 7.46 7.61 7.61 153,416
Dec 22, 2025 7.80 7.90 7.14 7.82 7.82 383,294
Dec 19, 2025 7.92 8.16 7.77 8.03 8.03 241,504
Dec 18, 2025 8.09 8.44 7.84 7.92 7.92 242,430
Dec 17, 2025 8.32 8.38 7.95 7.98 7.98 114,294
Dec 16, 2025 8.18 8.43 8.18 8.32 8.32 116,479
Dec 15, 2025 8.53 9.26 8.07 8.18 8.18 138,116
Dec 12, 2025 8.44 8.65 8.14 8.45 8.45 154,810
Dec 11, 2025 8.48 8.93 8.31 8.42 8.42 154,887
Dec 10, 2025 8.42 8.68 8.23 8.44 8.44 194,855
Dec 9, 2025 9.00 9.16 8.38 8.41 8.41 172,358
Dec 8, 2025 9.14 9.17 8.87 9.01 9.01 96,013
Dec 5, 2025 9.34 9.53 8.98 9.05 9.05 143,699
Dec 4, 2025 9.18 9.63 9.18 9.35 9.35 113,823
Dec 3, 2025 9.00 9.36 8.85 9.26 9.26 131,011
Dec 2, 2025 9.42 9.91 8.82 8.96 8.96 140,869
Dec 1, 2025 9.75 9.90 9.30 9.40 9.40 132,136
Nov 28, 2025 10.00 10.04 9.76 9.81 9.81 78,421
Nov 26, 2025 9.97 10.22 9.80 9.83 9.83 133,543
Nov 25, 2025 9.88 10.28 9.81 9.99 9.99 162,534
Nov 24, 2025 9.86 10.15 9.79 9.84 9.84 178,604
Nov 21, 2025 8.73 10.00 8.37 9.85 9.85 323,469
Nov 20, 2025 9.32 9.72 8.65 8.80 8.80 309,870
Nov 19, 2025 9.25 9.45 8.71 9.15 9.15 322,226
Nov 18, 2025 9.09 9.43 8.84 9.25 9.25 361,754
Nov 17, 2025 9.33 9.57 8.91 9.29 9.29 495,457
Nov 14, 2025 8.74 9.41 8.60 9.27 9.27 256,762
Nov 13, 2025 9.42 9.53 8.40 8.91 8.91 382,179
Nov 12, 2025 9.79 10.04 9.46 9.52 9.52 151,118
Nov 11, 2025 9.61 10.00 9.51 9.84 9.84 239,867
Nov 10, 2025 9.86 10.00 9.54 9.67 9.67 235,419
Nov 7, 2025 10.05 10.28 9.00 9.71 9.71 371,564
Nov 6, 2025 10.63 10.63 9.35 10.05 10.05 566,479
Nov 5, 2025 9.98 10.17 9.72 9.79 9.79 227,557
Nov 4, 2025 10.18 10.52 9.78 9.99 9.99 219,393
Nov 3, 2025 10.34 11.30 10.22 10.36 10.36 327,746
Oct 31, 2025 10.63 10.65 10.10 10.19 10.19 163,578
Oct 30, 2025 10.70 10.94 10.19 10.64 10.64 142,346
Oct 29, 2025 10.70 11.12 10.38 10.81 10.81 231,370
Oct 28, 2025 10.30 10.74 10.29 10.72 10.72 226,126
Oct 27, 2025 10.50 10.50 10.16 10.35 10.35 124,699
Oct 24, 2025 10.27 10.49 10.03 10.45 10.45 221,281
Oct 23, 2025 9.96 10.14 9.82 10.08 10.08 134,887
Oct 22, 2025 10.07 10.07 9.71 9.93 9.93 107,845
Oct 21, 2025 10.09 10.14 9.94 10.07 10.07 124,614
Oct 20, 2025 9.94 10.19 9.87 10.09 10.09 167,626
Oct 17, 2025 9.41 10.12 9.41 9.95 9.95 308,385
Oct 16, 2025 9.68 10.49 9.36 9.51 9.51 305,644
Oct 15, 2025 9.36 9.71 9.20 9.62 9.62 217,468
Oct 14, 2025 8.95 9.65 8.69 9.30 9.30 261,415
Oct 13, 2025 9.05 9.35 8.50 9.09 9.09 142,756
Oct 10, 2025 9.14 9.21 8.74 8.95 8.95 180,355
Oct 9, 2025 9.15 9.30 8.96 9.16 9.16 125,691
Oct 8, 2025 8.78 9.21 8.65 9.11 9.11 237,423
Oct 7, 2025 8.70 8.86 8.55 8.73 8.73 148,529
Oct 6, 2025 8.74 8.94 8.58 8.73 8.73 164,260
Oct 3, 2025 7.94 8.86 7.94 8.71 8.71 388,271
Oct 2, 2025 7.84 7.97 7.77 7.88 7.88 129,524
Oct 1, 2025 7.98 8.10 7.52 7.96 7.96 248,376
Sep 30, 2025 7.74 8.12 7.54 8.07 8.07 182,526
Sep 29, 2025 7.55 7.85 7.41 7.78 7.78 138,400
Sep 26, 2025 7.33 7.71 7.33 7.55 7.55 97,715
Sep 25, 2025 7.36 7.36 7.10 7.32 7.32 153,230
Sep 24, 2025 7.43 7.56 7.32 7.46 7.46 171,116
Sep 23, 2025 7.53 7.75 7.34 7.45 7.45 177,372
Sep 22, 2025 7.15 7.69 6.98 7.53 7.53 170,395

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
CVRx, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CVRX, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation